Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In a phase-3 trial including over 2500 overweight and obese individuals (baseline weight 233lb on average), the subjects achieved up to a 20.9% (about 48lb) mean reduction in body weight after 72 weeks at the dose of 15mg/weekly [11]
Such information is provided for informational purposes only and is not meant to be a substitute for medical advice
Regionally, North America and Europe lead in premium product adoption, while Asia-Pacific shows the fastest growth, particularly in South Korea and China where innovative delivery systems are emerging
Wang W, Yang LL, Luo SM, Ma JY, Zhao Y, Shen W, et al
US$ 25.57
US$ 24.55
US$ 26.16
